Trial Profile
A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of the Dose-Response Profile of V-101 Cream in Subjects With Erythematous Rosacea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2018
Price :
$35
*
At a glance
- Drugs Oxymetazoline (Primary)
- Indications Erythema
- Focus Therapeutic Use
- Sponsors Vicept Therapeutics
- 30 Apr 2014 New trial record